Answer
Cometriq (cabozantinib) is contraindicated in patients with hypersensitivity to cabozantinib or any of the excipients listed in section 6.1 of its SmPC.
Sources for this answer
- COMETRIQ 20 & 80 mg hard capsulesIpsen Ltd · emc · SmPC §4.3 Contraindications · Version 16Document updated
Sources checked